Jonas Sven Peter Jarvius
Founder chez Q-LINEA AB
Profil
Jonas Sven Peter Jarvius is the founder of Q-linea AB, a company founded in 2008.
He holds the title of President at Q-linea AB starting in 2024.
Dr. Jarvius is also the founder of Moleculink AB.
Currently, Dr. Jarvius is the Chairman at Umbrella Science AB.
In the past, Dr. Jarvius worked as the Chief Executive Officer at Ginolis AB and as a Director at Quiapeg Pharmaceuticals Holding AB.
He also held the position of Principal at the University of Uppsala.
Dr. Jarvius's education includes a doctorate degree from the University of Uppsala, conferred in 2006, and a graduate degree from the University of Uppsala, conferred in 1999.
Postes actifs de Jonas Sven Peter Jarvius
| Sociétés | Poste | Début |
|---|---|---|
| Q-LINEA AB | Founder | 03/11/2009 |
| Umbrella Science AB | Chairman | - |
Anciens postes connus de Jonas Sven Peter Jarvius
| Sociétés | Poste | Fin |
|---|---|---|
Ginolis AB
 Ginolis AB Miscellaneous ManufacturingProducer Manufacturing Ginolis AB develops components in polymer by first producing the parts in original through different methods for sculpting silicon and glass wafers. These originals are transferred to molds in which the final components are manufactured through time-effective and thus economical favorable polymer replication processes. The polymers themselves, compared with silicon micromechanics, could also add material property advantages with the vast variety of materials available. They can with this platform serve many different fields all with the same need of precision and complexity. Ginolis AB has the skill and experience to integrate different functions onto the very same chip in order to achieve functions that, if they are at all possible to manufacture with traditional technique, needs several parts assembled to mechanical systems with higher cost for the parts as a consequence. These functions include nano- and microfludic channels, surface chemistry, electrical wave guides and connectors, refractive and diffractive micro-optics. | Chief Executive Officer | - |
| University of Uppsala | Corporate Officer/Principal | - |
| QUIAPEG PHARMACEUTICALS HOLDING AB | Director/Board Member | - |
Moleculink AB
 Moleculink AB Electronic Equipment/InstrumentsElectronic Technology Moleculink AB provides diagnostic products for life science research purposes. The firm provides products and services for human protein biomarker research and development. It offers analysis service for comprehensive protein biomarker analyses based on Proseek Multiplex. The company was founded by Dag Åke Ulf Landegren, Björn Lennart Ekström, Mårten Winge, Johan Erik Simon Fredriksson, Jonas Sven Peter Jarvius, Bernitz Mats Bo Johan Nilsson, and Mats Gullberg in 2004 and is headquartered in Uppsala, Sweden. | Founder | - |
Formation de Jonas Sven Peter Jarvius
| University of Uppsala | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| Q-LINEA AB | Health Technology |
| QUIAPEG PHARMACEUTICALS HOLDING AB | Health Technology |
| Entreprise privées | 3 |
|---|---|
Moleculink AB
Moleculink AB Electronic Equipment/InstrumentsElectronic Technology Moleculink AB provides diagnostic products for life science research purposes. The firm provides products and services for human protein biomarker research and development. It offers analysis service for comprehensive protein biomarker analyses based on Proseek Multiplex. The company was founded by Dag Åke Ulf Landegren, Björn Lennart Ekström, Mårten Winge, Johan Erik Simon Fredriksson, Jonas Sven Peter Jarvius, Bernitz Mats Bo Johan Nilsson, and Mats Gullberg in 2004 and is headquartered in Uppsala, Sweden. | Electronic Technology |
Ginolis AB
Ginolis AB Miscellaneous ManufacturingProducer Manufacturing Ginolis AB develops components in polymer by first producing the parts in original through different methods for sculpting silicon and glass wafers. These originals are transferred to molds in which the final components are manufactured through time-effective and thus economical favorable polymer replication processes. The polymers themselves, compared with silicon micromechanics, could also add material property advantages with the vast variety of materials available. They can with this platform serve many different fields all with the same need of precision and complexity. Ginolis AB has the skill and experience to integrate different functions onto the very same chip in order to achieve functions that, if they are at all possible to manufacture with traditional technique, needs several parts assembled to mechanical systems with higher cost for the parts as a consequence. These functions include nano- and microfludic channels, surface chemistry, electrical wave guides and connectors, refractive and diffractive micro-optics. | Producer Manufacturing |
| Umbrella Science AB |
